Literature DB >> 18924132

Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells.

Frank Schmitz1, Antje Heit, Stefan Dreher, Katharina Eisenächer, Jörg Mages, Tobias Haas, Anne Krug, Klaus-Peter Janssen, Carsten J Kirschning, Hermann Wagner.   

Abstract

The mammalian target of rapamycin (mTOR) can be viewed as cellular master complex scoring cellular vitality and stress. Whether mTOR controls also innate immune-defenses is currently unknown. Here we demonstrate that TLR activate mTOR via phosphoinositide 3-kinase/Akt. mTOR physically associates with the MyD88 scaffold protein to allow activation of interferon regulatory factor-5 and interferon regulatory factor-7, known as master transcription factors for pro-inflammatory cytokine- and type I IFN-genes. Unexpectedly, inactivation of mTOR did not prevent but increased lethality of endotoxin-mediated shock, which correlated with increased levels of IL-1beta. Mechanistically, mTOR suppresses caspase-1 activation, thus inhibits release of bioactive IL-1beta. We have identified mTOR as indispensable component of PRR signal pathways, which orchestrates the defense program of innate immune cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18924132     DOI: 10.1002/eji.200838761

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  99 in total

1.  FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages.

Authors:  Wuqiang Fan; Hidetaka Morinaga; Jane J Kim; Eunju Bae; Nathanael J Spann; Sven Heinz; Christopher K Glass; Jerrold M Olefsky
Journal:  EMBO J       Date:  2010-11-02       Impact factor: 11.598

Review 2.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

3.  Mammalian target of rapamycin (mTOR) regulates TLR3 induced cytokines in human oral keratinocytes.

Authors:  Jiawei Zhao; Manjunatha R Benakanakere; Kavita B Hosur; Johnah C Galicia; Michael Martin; Denis F Kinane
Journal:  Mol Immunol       Date:  2010-08-21       Impact factor: 4.407

4.  Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy.

Authors:  Changyoun Kim; Edward Rockenstein; Brian Spencer; Hyung-Koo Kim; Anthony Adame; Margarita Trejo; Klodjan Stafa; He-Jin Lee; Seung-Jae Lee; Eliezer Masliah
Journal:  Cell Rep       Date:  2015-10-17       Impact factor: 9.423

5.  mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS.

Authors:  Heth R Turnquist; Jon Cardinal; Camila Macedo; Brian R Rosborough; Tina L Sumpter; David A Geller; Diana Metes; Angus W Thomson
Journal:  Blood       Date:  2010-03-24       Impact factor: 22.113

Review 6.  IRF7: activation, regulation, modification and function.

Authors:  S Ning; J S Pagano; G N Barber
Journal:  Genes Immun       Date:  2011-04-14       Impact factor: 2.676

Review 7.  Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure.

Authors:  Toshinori Aoyagi; Takashi Matsui
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

8.  Tuberous sclerosis 1 (Tsc1)-dependent metabolic checkpoint controls development of dendritic cells.

Authors:  Yanyan Wang; Gonghua Huang; Hu Zeng; Kai Yang; Richard F Lamb; Hongbo Chi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-26       Impact factor: 11.205

9.  The Cardiomyocyte as a Source of Cytokines in Cardiac Injury.

Authors:  Toshinori Aoyagi; Takashi Matsui
Journal:  J Cell Sci Ther       Date:  2011-12-01

10.  The phosphoproteome of toll-like receptor-activated macrophages.

Authors:  Gabriele Weintz; Jesper V Olsen; Katja Frühauf; Magdalena Niedzielska; Ido Amit; Jonathan Jantsch; Jörg Mages; Cornelie Frech; Lars Dölken; Matthias Mann; Roland Lang
Journal:  Mol Syst Biol       Date:  2010-06-08       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.